WALTHAM, MASSACHUSETTS Lease Dated November 3, 2020 (“Effective Date”)Lease Agreement • March 1st, 2021 • Translate Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS INSTRUMENT IS AN INDENTURE OF LEASE (this “Lease”) in which Landlord and Tenant are the parties hereinafter named, and which relates to space in the building known as, and having an address at, 200 West Street, Waltham, Massachusetts 02451.
TRANSLATE BIO, INC. NONSTATUTORY STOCK OPTION AGREEMENT Granted Under 2021 Inducement Stock Incentive PlanNonstatutory Stock Option Agreement • March 1st, 2021 • Translate Bio, Inc. • Biological products, (no disgnostic substances)
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
TRANSLATE BIO, INC. NONSTATUTORY STOCK OPTION AGREEMENT Granted Under 2021 Inducement Stock Incentive PlanNonstatutory Stock Option Agreement • March 1st, 2021 • Translate Bio, Inc. • Biological products, (no disgnostic substances)
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
Company Letterhead]Severance Agreement • March 1st, 2021 • Translate Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
As we discussed, your employment with Translate Bio (the “Company”) will end effective December 27, 2020 (the “Separation Date”). As we also discussed, you will be eligible to receive the severance benefits described in paragraph 1 below if you sign and return this letter agreement to me by January 18, 2021 (but no earlier than the Separation Date) and do not revoke your agreement (as described below).
TRANSLATE BIO, INC. NONSTATUTORY STOCK OPTION AGREEMENT Granted Under 2021 Inducement Stock Incentive PlanNonstatutory Stock Option Agreement • March 1st, 2021 • Translate Bio, Inc. • Biological products, (no disgnostic substances)
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
